Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma

Figures

• 

  Figure 1. Overall survival according to (A) age, (B) Eastern Cooperation Oncology Group (ECOG) scores, (C) serum lactate dehydrogenase (LDH), (D) Ki-67, and (E) white cell count (WCC).

• 

  Figure 2. Nomogram evaluation in the patients with mantle cell lymphoma. To use the nomogram, the value attributed to an individual patient is located on each variable axis, and a line is drawn upwards to determine the number of points received for each variable value. To determine the 1-year, 2-year and 3-year overall survival probability, a line is drawn downwards from the total points’ axis, where the total points represent a sum of points of each variable, to the survival axis. ECOG, Eastern Cooperation Oncology Group; LDH, lactate dehydrogenase; ULN, upper limits of normal; WCC, white cell count.

• 

  Figure 3. The calibration curve for predicting patient survival at (A) 1 year and (B) 3 years in the primary cohort.

• 

  Figure 4. Time-dependent receiver operating characteristic curves from the nomogram, IPI and MIPI for (A) 1-year, (B) 2-year and (C) and 3-year overall survival in the primary cohort. AUC, area under the curve; IPI, International Prognostic Index; MIPI, Mantle cell lymphoma International Prognostic Index.

• 

  Figure 5. The calibration curve for predicting patient survival at (A) 1 year and (B) 3 year in the validation cohort.

• 

  Figure 6. Time-dependent receiver operating characteristic curves from the nomogram, IPI and MIPI for 1 year (A), 2 year (B) and 3 year (C) overall survival in the validation cohort. AUC, area under the curve; IPI, International Prognostic Index; MIPI, Mantle cell lymphoma International Prognostic Index.